Meda AGM bulletin

Meda AGM bulletin 

The Annual General Meeting of Meda AB (publ), corporate ID 556427-2812, Box
906,SE-170 09 Solna, Sweden, on Tuesday, May 6, 2008, resolved that the dividend
for the 2007 financial year will be SEK 0.75 per share. 

The AGM adopted the consolidated financial statements of the group and the
financial statements of the parent company. The AGM decided upon discharge from
liability of the board and the CEO. 

All proposals of the nomination committee were adopted, such as the re-election
of board members and auditors, as well as the fees for the board and the
auditors. The proposal made by the board in respect of the remuneration
principles for Meda's executives was adopted. The AGM authorised the board to
take share issue decisions according to the board's proposal. 

The complete AGM resolutions are available at Meda's head office at Pipers väg
2, Solna, Sweden. Phone: +46 8 630 1900. Upon request, they will be sent
cost-free to shareholders when addresses are provided. The complete AGM
resolutions will also be available on www.meda.se.


The board of Meda AB (publ)


For more information, please contact:

Anders Larnholt, Investor Relations, tel. +46 8 630 19 62, +46 709 458 878
email: anders.larnholt@meda.se

MEDA AB (publ) is an international specialty pharma company that concentrates on
marketing and market-adapted product development. Acquisitions and long-term
partnerships are fundamental factors that drive the company's strategy. Meda is
represented with own organisations in 26 countries and with more than 1 500
employees within marketing and sales. Meda's products are sold in approximately
120 countries world-wide. The Meda share is listed under Large Cap on the OMX
Nordic Stock Exchange. Find out more, visit www.meda.se.